Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jun 2023 for Lyra Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-4.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
NBVM GP, LLC: trading record in brief
Filings by NBVM GP, LLC span 2 companies, the busiest being Lyra Therapeutics, Inc. and Couchbase, Inc. We count 3 filings; the first trade dates from 26 July 2021 and the latest from 31 May 2023.
Purchases make up the whole of the open-market record (2 purchases). The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 1 purchase and no sales on the market.
The record was last updated on 2 June 2023 with an open-market purchase in Lyra Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to NBVM GP, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
403,858 shares@ €2.272117.9% of flowCommon StockSEC:0000899243-23-014352:0
Canonical exit: 29 Aug 2023 (T+90)
1,076,851 shares@ €3.89882.1% of flowCommon StockSEC:0000899243-22-014796:0
Canonical exit: 11 Jul 2022 (T+90)
2,402,147 sharesCommon StockSEC:0001209191-21-048264:0
3 of 3 declarations
